Copyright
©The Author(s) 2016.
World J Gastrointest Endosc. Dec 16, 2016; 8(20): 763-769
Published online Dec 16, 2016. doi: 10.4253/wjge.v8.i20.763
Published online Dec 16, 2016. doi: 10.4253/wjge.v8.i20.763
Ref. | # Patients | Depth of invasion | Histology | Margins | Remission | Recurrence | Survival |
Manner et al[12] | 21 | sm1 | Well to moderately differentiated, no lymphovascular invasion | Lateral margins negative in 12 | 95% at mean 5.3 mo | 28% at mean 62 mo (range 45-89) | 67% estimated 5-yr survival |
Alvarez Herrero et al[14] | 18 | sm1 and sm2/3 | Well, moderately and poorly differentiated, some with lymphovascular invasion | Not reported | Not reported | 17% | Not reported |
Tian et al[15] | 29 | sm1 and sm2-3 | Not reported | Not reported | Not reported | Not reported | 62% with median duration 34.8 mo |
Manner et al[13] | 66 | sm1 | Well to moderately differentiated, no lymphovascular invasion | Not reported | 84% at mean 4.5 mo | 21% at mean 22 mo (range 6-60) | 84% estimated 5-yr survival |
- Citation: Ballard DD, Choksi N, Lin J, Choi EY, Elmunzer BJ, Appelman H, Rex DK, Fatima H, Kessler W, DeWitt JM. Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection. World J Gastrointest Endosc 2016; 8(20): 763-769
- URL: https://www.wjgnet.com/1948-5190/full/v8/i20/763.htm
- DOI: https://dx.doi.org/10.4253/wjge.v8.i20.763